Ecuador vs Guatemala: Antiretroviral therapy coverage for PMTCT
Ecuador
85.0%
in 2024
Guatemala
82.0%
in 2023
Ecuador rank
35th
Guatemala rank
38th
Antiretroviral therapy coverage for PMTCT over time
- Ecuador
- Guatemala
How they compare
Ecuador currently reports 85.0% against 82.0% in Guatemala, a difference of 3.0%.
The two have swapped places 8 times across 24 shared years of data; in 2000 it was Guatemala ahead.
Ecuador ranks 35th and Guatemala ranks 38th of 84 countries.
Across the 3 decades both report, Ecuador averaged higher in 1 and Guatemala in 2.
Head to head by decade
| Decade | Ecuador | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.8% | 23.8% | 7.0% | Guatemala |
| 2010s | 45.6% | 54.3% | 8.7% | Guatemala |
| 2020s | 76.2% | 75.0% | 1.2% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Ecuador or Guatemala?
- Ecuador, at 85.0% against 82.0% in Guatemala as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Ecuador and Guatemala?
- 3.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Guatemala?
- 24 years are reported by both, from 2000 to 2023.
- How do Ecuador and Guatemala rank globally for antiretroviral therapy coverage for pmtct?
- Ecuador ranks 35th and Guatemala ranks 38th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).